17 studies found for:    LCIG
Show Display Options
Rank Status Study
1 Completed A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
Condition: Parkinson's Disease
Interventions: Drug: ND0612;   Drug: LCIG
2 Recruiting Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
Condition: Advanced Parkinson's Disease
Intervention:
3 Enrolling by invitation A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)
Condition: Advanced Parkinson's Disease
Intervention: Drug: ABT-SLV187
4 Completed
Has Results
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
5 Not yet recruiting Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease
Condition: Parkinson Disease
Intervention: Dietary Supplement: different diets
6 Completed
Has Results
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa carbidopa intestinal gel (LCIG);   Drug: Placebo Gel;   Drug: Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets;   Drug: Placebo (PBO) oral capsules;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
7 Completed
Has Results
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa carbidopa intestinal gel (LCIG);   Drug: Placebo gel;   Drug: Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets;   Drug: Placebo (PBO) oral capsules;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
8 Not yet recruiting An Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: ABT-SLV187;   Drug: optimized antiparkinsonian treatment
9 Completed
Has Results
Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources
Condition: Parkinson's Disease
Intervention:
10 Completed
Has Results
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Dyskinesias;   Parkinson's Disease;   Severe Motor Fluctuations
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
11 Completed
Has Results
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
Condition: Advanced Idiopathic Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel (LCIG);   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: percutaneous endoscopic gastrostomy tube (PEG tube);   Device: jejunal extension tube (J-tube)
12 Completed
Has Results
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
13 Completed A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Intervention: Drug: Levodopa-Carbidopa Intestinal Gel
14 Completed
Has Results
Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: ABT-SLV187;   Drug: Oral Levodopa/Carbidopa;   Device: Infusion Pump: CADD-Legacy® 1400 Pump;   Device: NJ-Tube: Silicon ED Tube;   Device: Adaptor: Hakko Adaptor
15 Recruiting Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Condition: Advanced Parkinson's Disease
Intervention:
16 Recruiting Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Intervention:
17 Active, not recruiting Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump

Indicates status has not been verified in more than two years